Attorneys, FDA Hit The Road To Instruct On Mobile Health Regs
This article was originally published in The Gray Sheet
Executive Summary
Attorneys, FDA and industry groups have teamed up to tour the country and educate innovators on how to navigate mobile medical app regulations.
You may also be interested in...
FDA Emphasizes “Deregulatory” Efforts In Mobile Medical Apps Final Guidance
In a long-awaited final guidance, FDA affirmed its plan to practice enforcement discretion for most mobile medical apps, except those applications that present the same risks as conventional FDA-regulated devices. Some digital health stakeholders praised the guidance, while others wished FDA has waited.
Industry Meets With FDA On Mobile Health Regulatory Plan
Members of the mHealth Regulatory Coalition hope their recent closed-door meeting with FDA will help lay the groundwork for clarifying which mobile health devices and software applications will face agency oversight.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.